Literature DB >> 2100271

Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity.

I Ranløv1, F Hardt.   

Abstract

15 consecutive persons aged under 50 with an overweight exceeding 75% were examined clinically, biochemically and with liver biopsy after gastric bypass (7 patients) or gastroplasty (8 patients). After 1 year the occurrence of steatosis had fallen from 73 to 40% which, together with a marked decrease in individual gradings of fatty changes, represented a significant regression of the steatosis. Likewise, discrete inflammatory and granulomatous changes largely disappeared. In no case was fibrosis present. Serum alkaline phosphatases preoperatively increased above normal range in 20% but their mean level was significantly reduced after 12 months of weight loss. Other liver function tests remained normal and stable. In contrast to published experience with jejunoileal bypass operations liver steatosis associated with morbid obesity seems to be morphologically and biochemically reversed together with the weight reduction obtained by gastroplasty or gastric bypass.

Entities:  

Mesh:

Year:  1990        PMID: 2100271     DOI: 10.1159/000200499

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  10 in total

1.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

2.  Bariatric Surgery in Cirrhotic Patients: Is It Safe?

Authors:  Hafsa Younus; Amit Sharma; Rosa Miquel; Alberto Quaglia; Subba Rao Kanchustambam; Kirstin A Carswell; Ameet G Patel
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

3.  Advances in the treatment of nonalcoholic fatty liver disease.

Authors:  Sanjeev R Mehta
Journal:  Ther Adv Endocrinol Metab       Date:  2010-06       Impact factor: 3.565

4.  Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.

Authors:  Jun Chen; Jayant A Talwalkar; Meng Yin; Kevin J Glaser; Schuyler O Sanderson; Richard L Ehman
Journal:  Radiology       Date:  2011-04-01       Impact factor: 11.105

5.  Long-term consequences after jejunoileal bypass for morbid obesity.

Authors:  M P Hocking; G L Davis; D A Franzini; E R Woodward
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 6.  Bariatric surgery for non-alcoholic steatohepatitis in obese patients.

Authors:  Norberto C Chavez-Tapia; Felix I Tellez-Avila; Tonatiuh Barrientos-Gutierrez; Nahum Mendez-Sanchez; Javier Lizardi-Cervera; Misael Uribe
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

7.  A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease.

Authors:  Xin Chu; Kelsey Karasinski; Sean Donellan; Scott Kaniper; G Craig Wood; Weixing Shi; Michael A Edwards; Rohit Soans; Christopher D Still; Glenn S Gerhard
Journal:  Langenbecks Arch Surg       Date:  2019-12-11       Impact factor: 3.445

8.  Treatment of Nonalcoholic Fatty Liver Disease.

Authors:  Suthat Liangpunsakul; Naga Chalasani
Journal:  Curr Treat Options Gastroenterol       Date:  2003-12

Review 9.  Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?

Authors:  Shuja Hafeez; Mohamed H Ahmed
Journal:  J Obes       Date:  2013-01-29

10.  Hepatic steatosis as a potential risk factor for major hepatic resection.

Authors:  K E Behrns; G G Tsiotos; N F DeSouza; M K Krishna; J Ludwig; D M Nagorney
Journal:  J Gastrointest Surg       Date:  1998 May-Jun       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.